Published • loading... • Updated
Are RMAX, KALV, GBTG Obtaining Fair Deals for Their Shareholders?
Halper Sadeh said the deals could limit competing bids and may leave shareholders with lower payouts or reduced disclosures.
- On Friday, investor rights law firm Halper Sadeh LLC announced investigations into potential securities law violations and breaches of fiduciary duties across multiple corporate transactions, including deals involving Catalyst Pharmaceuticals, TruBridge, and Select Medical.
- Halper Sadeh LLC represents investors worldwide investigating corporate misconduct and securities fraud, offering to discuss legal rights and options regarding proposed sales at no cost or obligation.
- Current investigations target Catalyst Pharmaceuticals' sale to Angelini Pharma, TruBridge's $26.25-per-share sale to Inventurus Knowledge Solutions, ACRES Commercial Realty's merger, and Modiv Industrial's sale to Global Net Lease.
- The firm scrutinizes whether proposed transactions restrict superior competing offers and whether insiders may receive substantial financial benefits unavailable to ordinary shareholders.
- Upon closing the Modiv Industrial transaction, shareholders are expected to own approximately 11% of the combined company, while the firm handles matters on a contingent fee basis with no out-of-pocket expenses.
Insights by Ground AI
34 Articles
34 Articles
Coverage Details
Total News Sources34
Leaning Left2Leaning Right5Center14Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
C 67%
R 24%
Factuality
To view factuality data please Upgrade to Premium
